Case Report: Prenatal diagnostic challenges in a fetus with Noonan syndrome despite negative PGT: a case of de novo PTPN11 mutation


Creative Commons License

Yılmaz Y., Ince O., Dağdelen C., Tunç Acar T., Pınar G., Öz Ö. F., ...Daha Fazla

Türk Alman Jinekoloji Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2025, cilt.1, sa.1, ss.86-87, (Tam Metin Bildiri)

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Cilt numarası: 1
  • Basıldığı Şehir: Antalya
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.86-87
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Case Report: Prenatal diagnostic challenges in a fetus with Noonan syndrome despite negative PGT: a case of de novo PTPN11 mutation

Yavuz Yılmaz1 , Osman İnce2 , Cem Dağdelen2 , Tuğçe Tunç Acar2 , Gizem Pınar2 , Ömer Faruk Öz1 , Can Dinç1 , İbrahim İnaç Mendilcioğlu2

1 Department of Obstetrics and Gynecology, Akdeniz University Hospital, School of Medicine,Antalya,Turkey

2 Department of Perinatology,Akdeniz University Hospital, School of Medicine,Antalya,Turkey

INTRODUCTION: Noonan syndrome is a relatively common autosomal dominant genetic disorder with an estimated incidence of 1 in 1,000 to 2,500 live births. It is classified within the group of RASopathies, a family of syndromes caused by mutations affecting the RAS-MAPK signaling pathway. The most frequently involved gene is PTPN11.Clinically, it is characterized by a variable phenotype including short stature, facial dysmorphism, congenital heart defects, developmental delay, and lymphatic anomalies. Prenatal diagnosis of Noonan syndrome is challenging due to the nonspecific and variable nature of sonographic findings. As the pregnancy progresses, additional anomalies may become apparent, such as polyhydramnios, fetal hydrops, pleural effusions, cardiac defects, and growth restriction. Structural cardiac anomalies, particularly hypertrophic cardiomyopathy or septal defects, are common and often serve as diagnostic clues. Craniofacial features like hypertelorism, micrognathia, and a depressed nasal bridge may also be noted on detailed anatomical survey or ultrasonography (USG).

CASE: A 32-year-old gravida 3, para 2 woman was referred to our perinatology clinic due to a history of two neonatal deaths, both resulting from multiple congenital anomalies. Her first pregnancy ended with the neonatal death of a female infant on day 7, born at 35 weeks via cesarean section. The second pregnancy also ended in neonatal death on day 3; genetic analysis of the fetus identified a homozygous ETFB variant, classified as a Variant of Uncertain Significance, consistent with a potential diagnosis of Glutaric Aciduria Type IIB. Both parents were heterozygous carriers of the same variant. The current pregnancy was conceived via IVF following preimplantation genetic testing (PGT) to exclude the ETFB variant. Despite PGT, new sonographic anomalies prompted a recommendation for amniocentesis to confirm the genetic status of the fetus; however, the parents declined all invasive testing. Serial detailed USG examination revealed multiple findings, including mild lateral ventriculomegaly (12mm)(fig.1), obliterated cavum septum pellucidum (fig.2), micrognathia, hypertelorism, leftward cardiac axis deviation and concentric myocardial hypertrophy (fig.3), a small inlet-type ventricular septal defect (VSD), renal pelvis dilatation (r6 mm). Fetal magnetic resonance imaging (MRI) was performed due to ventriculomegaly, and no additional pathological findings were identified. At 37w2d, an elective cesarean section was performed due to previous cesarean delivery and contraction pain. A male infant was delivered in breech presentation, 3350 grams, apgar scores 6/7. Physical examination revealed, including micrognathia and hypertelorism. The newborn was admitted to the NICU for further evaluation. Postnatal whole exome sequencing (WES) identified a pathogenic variant in the PTPN11 gene, confirming a diagnosis of Noonan syndrome. CONCLUSION: In this case emphasizes the role of detailed prenatal imaging in raising suspicion for Noonan syndrome, even in the absence of classic first-trimester markers. It also highlights the limitations of PGT when underlying genetic complexity or de novo pathogenic mutations are involved. Despite the absence of early nuchal thickening and the presence of normal first-trimester screening, progressive structural anomalies raised prenatal suspicion.

Keywords: Noonan Syndrome, PGT, prenatal diagnosis, RASopathies, fetal anomaly, Prenatal ultrasonography